Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.

NCT06675214 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

586

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
De-escalation Therapy

Interventions

DRUG: Full course of PD-1/PD-L1 blockades
DRUG: Cisplatin-based induction chemotherapy
RADIATION: Standard-dose IMRT
RADIATION: Gradient Fractionated IMRT
DRUG: Concurrent Chemotherapy

Sponsor

Sun Yat-sen University